- Home
- NBIX vs GL Comparison
NBIX vs GL Comparison
Compare NBIX & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- GL
- Stock Information
- Founded
- NBIX 1992
- GL 1900
- Country
- NBIX United States
- GL United States
- Employees
- NBIX N/A
- GL N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- GL Life Insurance
- Sector
- NBIX Health Care
- GL Finance
- Exchange
- NBIX Nasdaq
- GL Nasdaq
- Market Cap
- NBIX 12.0B
- GL 10.2B
- IPO Year
- NBIX 1996
- GL N/A
- Fundamental
- Price
- NBIX $123.02
- GL $121.86
- Analyst Decision
- NBIX Strong Buy
- GL Buy
- Analyst Count
- NBIX 20
- GL 11
- Target Price
- NBIX $163.20
- GL $137.73
- AVG Volume (30 Days)
- NBIX 1.6M
- GL 626.7K
- Earning Date
- NBIX 05-05-2025
- GL 07-23-2025
- Dividend Yield
- NBIX N/A
- GL 0.89%
- EPS Growth
- NBIX N/A
- GL 17.62
- EPS
- NBIX 2.96
- GL 12.31
- Revenue
- NBIX $2,412,600,000.00
- GL $5,842,352,000.00
- Revenue This Year
- NBIX $15.99
- GL $7.96
- Revenue Next Year
- NBIX $14.93
- GL $5.35
- P/E Ratio
- NBIX $41.60
- GL $9.90
- Revenue Growth
- NBIX 21.73
- GL 5.41
- 52 Week Low
- NBIX $84.23
- GL $76.55
- 52 Week High
- NBIX $157.98
- GL $133.76
- Technical
- Relative Strength Index (RSI)
- NBIX 62.85
- GL 51.46
- Support Level
- NBIX $117.59
- GL $119.67
- Resistance Level
- NBIX $125.63
- GL $123.03
- Average True Range (ATR)
- NBIX 2.98
- GL 2.20
- MACD
- NBIX -0.02
- GL 0.15
- Stochastic Oscillator
- NBIX 72.90
- GL 64.35
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About GL Globe Life Inc.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.